Abstract:BACKGROUND:The aberrant activation of Ras signaling is associated with human diseases including hematological malignancies and vascular disorders. So far the pathological roles of activated Ras signaling in hematopoiesis and vasculogenesis are largely unknown.METHODS:A conditional Cre/loxP transgenic strategy was used to mediate the specific expression of a constitutively active form of human N-Ras in zebrafish endothelial and hematopoietic cells driven by the zebrafish lmo2 promoter. The expression of hematopoietic and endothelial marker genes was analyzed both via whole mount in situ hybridization (WISH) assay and real-time quantitative PCR (qPCR). The embryonic vascular morphogenesis was characterized both by living imaging and immunofluorescence on the sections with a confocal microscopy, and the number of endothelial cells in the embryos was quantified by flow cytometry. The functional analyses of the blood circulation were carried out by fluorescence microangiography assay and morpholino injection.RESULTS:In the activated N-Ras transgenic embryos, the primitive hematopoiesis appeared normal, however, the definitive hematopoiesis of these embryos was completely absent. Further analysis of endothelial cell markers confirmed that transcription of arterial marker ephrinB2 was significantly decreased and expression of venous marker flt4 excessively increased, indicating the activated N-Ras signaling promotes the venous development at the expense of arteriogenesis during zebrafish embryogenesis. The activated N-Ras-expressing embryos showed atrophic axial arteries and expansive axial veins, leading to no definitive hematopoietic stem cell formation, the blood circulation failure and subsequently embryonic lethality.CONCLUSIONS:Our studies revealed for the first time that activated N-Ras signaling during the endothelial differentiation in vertebrates can disrupt the balance of arterial-venous specification, thus providing new insights into the pathogenesis of the congenital human vascular disease and tumorigenic angiogenesis.

Prdm16 amplifies Notch signaling and suppresses venous lineage specification to prevent arteriovenous malformations during vascular development

Prdm6 drives ductus arteriosus closure by promoting ductus arteriosus smooth muscle cell identity and contractility

PRDM16 determines specification of ventricular cardiomyocytes by suppressing alternative cell fates

Activated N-Ras Signaling Regulates Arterial-Venous Specification in Zebrafish

Notch Signaling in Vascular Smooth Muscle Regulates Angiogenesis

The Role ofNotch 1Activation in Cardiosphere Derived Cell Differentiation

PRDM16 orchestrates angiogenesis via neural differentiation in the developing brain

Nrarp Coordinates Endothelial Notch and Wnt Signaling to Control Vessel Density in Angiogenesis

The role of notch 1 activation in cardiosphere derived cell differentiation.

Nitric oxide synthase and reduced arterial tone contribute to arteriovenous malformation

Smad1/5 is acetylated in the dorsal aortae of the mouse embryo before the onset of blood flow, driving early arterial gene expression

Notch signaling in primary endothelial cells

A Notch‐dependent Transcriptional Hierarchy Promotes Mesenchymal Transdifferentiation in the Cardiac Cushion

Zfp36l1b protects angiogenesis through Notch1b/Dll4 and Vegfa regulation in zebrafish.

Notch-1 Signalling is Activated in Brain Arteriovenous Malformations in Humans.

Ets1-Related Protein is a Key Regulator of Vasculogenesis in Zebrafish

Temporal and embryonic lineage-dependent regulation of human vascular SMC development by NOTCH3

Hedgehog Signaling Induces Arterial Endothelial Cell Formation by Repressing Venous Cell Fate.

PRDM16 functions as a co-repressor in the BMP pathway to suppress neural stem cell proliferation

Notch transcriptional target tmtc1 maintains vascular homeostasis

Transcriptional regulators of arterial and venous identity in the developing mammalian embryo